HTB

Coinfections and complications

opportunistic infections, coinfections and complications

Unexplained vision loss in AIDS patients calls for fluorescein angiography

Incidence and prognosis of AIDS-related lymphoma have improved since the advent of HAART

HIV infection may trigger neurologic disorder

Nerve growth factor improves HIV-associated sensory neuropathy

AIDS-related lymphoma responds best to chemotherapy/HAART combination

Imiquimod and drug resistant herpes simplex

Can low-dose shark cartilage shrink KS?

Respiratory failure in PCP patients can recur after HAART initiated

Valcyte receives Dutch regulatory approval for treatment of AIDS-related CMV retinitis

Interferon shows some benefit in preventing AIDS-related opportunistic infections

CD4+ counts predictive of musculoskeletal manifestations of HIV infection

Effect of highly active antiretroviral therapy on frequency of oral warts

Cancer risk increased with AIDS

HAART lowers CIN recurrence risk in HIV-positive women

Roche’s valganciclovir for AIDS-related eye infections backed by FDA panel

Topical docosanol may be beneficial in treating HIV-related Kaposi’s sarcoma

Oral ganciclovir safe, effective for children co-infected with CMV and HIV

HIV related oral lesions are less common since HAART

HIV-1 protease inhibitor treatment clears human herpesvirus 8

Interferon-gamma treatment in azole-resistant oropharyngeal candidiasis

Opportunistic infections in the HAART era

Opportunistic illness and viral hepatitis co-infection

Highly active antiretroviral therapy should continue even if immune restoration syndrome develops

Topical cidofovir clears severe molluscum contagiosum in children with AIDS

Prevalence of psoriatic arthritis increasing among HIV-positive black Zambians

Human papilloma virus and HIV

HIV-related anal cancer incidence increased in long-term survivors

Post navigation